MARKET

ELUT

ELUT

Elutia Inc.
NASDAQ
1.070
0.000
0.00%
After Hours: 1.070 0 0.00% 16:10 03/27 EDT
OPEN
1.090
PREV CLOSE
1.070
HIGH
1.140
LOW
1.030
VOLUME
87.33K
TURNOVER
--
52 WEEK HIGH
2.990
52 WEEK LOW
0.5000
MARKET CAP
45.78M
P/E (TTM)
0.8302
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELUT last week (0316-0320)?
Weekly Report · 03/23 09:22
Elutia to present and hold investor meetings at Sidoti Small-Cap Virtual Investor Conference
Reuters · 03/17 12:04
Weekly Report: what happened at ELUT last week (0309-0313)?
Weekly Report · 03/16 09:21
Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win
TipRanks · 03/15 06:00
Elutia announces grants of inducement awards
TipRanks · 03/13 12:11
Elutia grants 460,000 inducement stock options under 2026 Inducement Award Plan
Reuters · 03/13 12:01
ELUTIA ANNOUNCES GRANTS OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 03/13 12:00
Aziyo Biologics Earnings Call: Cash, Risk and 41X
TipRanks · 03/13 00:04
More
About ELUT
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.

Webull offers Elutia Inc stock information, including NASDAQ: ELUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELUT stock methods without spending real money on the virtual paper trading platform.